MedicaidCoverageMedium impact
KMAP BULLETIN: Preferred Drug List Update – June 2025
Kansas Medicaid (KanCare)·KS·Pharmacy
Effective date
Jun 1, 2025
We identified it
Jun 21, 2026
Summary
KMAP has updated its Preferred Drug List effective June 1, 2025. Gabarone (gabapentin) becomes non-preferred, Wegovy (semaglutide) becomes preferred, and Gelnique (oxybutynin) and Qdolo (tramadol) are removed from the preferred list entirely.
Action Required
Before June 1, 2025: Billing team must update prior authorization requirements in billing system for affected medications. Update providers that Gabarone (gabapentin) will require prior auth as non-preferred drug, Gelnique (oxybutynin) and Qdolo (tramadol) will need prior authorization or alternative preferred drugs. Monitor KanCare MCO implementation dates as they may vary from state policy date.